Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
The American Journal of Managed Care
|
June 2, 2005
Tegaserod treatment for IBS: a model of indirect costs
Dean G Smith, Victoria Barghout, Kristijan H Kahler
Journal of Medical Economics
|
October 21, 2011
Evolutionary cost analysis of valsartan initiation among patients with hypertension: a time series approach
Peter Sun, Joanne Chang, Jie Zhang, et al.
American Journal of Clinical Dermatology
|
April 12, 2006
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age
Charles N Ellis, Kristijan H Kahler, Jens Grueger, et al.
Journal of the American Medical Directors Association
|
February 10, 2007
Is drug therapy for urinary incontinence used optimally in long-term care facilities?
Siva Narayanan, Annamaria Cerulli, Kristijan H Kahler, et al.
The Primary Care Companion for CNS Disorders
|
March 8, 2013
Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder
Haijun Tian, Safiya Abouzaid, Susan Gabriel, et al.
Pharmacoepidemiology and Drug Safety
|
March 4, 2006
Methods for evaluation of medication adherence and persistence using automated databases
Susan E Andrade, Kristijan H Kahler, Feride Frech, et al.
Alzheimer Disease and Associated Disorders
|
August 16, 2012
Patient adherence to transdermal rivastigmine after switching from oral donepezil: a retrospective claims database study
Haijun Tian, Safiya Abouzaid, Wei Chen, et al.
Journal of the American Academy of Dermatology
|
January 11, 2003
Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis
Margaret C Reilly, Philip T Lavin, Kristijan H Kahler, et al.
Bone
|
August 21, 2007
Consequences of poor compliance with bisphosphonates
Becky A Briesacher, Susan E Andrade, Robert A Yood, et al.
Pharmacoepidemiology and Drug Safety
|
March 6, 2003
Safety and patient tolerance of standard and slow-release formulations of NSAIDs
Michael Langman, Sheldon X Kong, Qiaoyi Zhang, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
The American Journal of Managed Care
|
June 2, 2005
Tegaserod treatment for IBS: a model of indirect costs
Dean G Smith, Victoria Barghout, Kristijan H Kahler
Journal of Medical Economics
|
October 21, 2011
Evolutionary cost analysis of valsartan initiation among patients with hypertension: a time series approach
Peter Sun, Joanne Chang, Jie Zhang, et al.
American Journal of Clinical Dermatology
|
April 12, 2006
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age
Charles N Ellis, Kristijan H Kahler, Jens Grueger, et al.
Journal of the American Medical Directors Association
|
February 10, 2007
Is drug therapy for urinary incontinence used optimally in long-term care facilities?
Siva Narayanan, Annamaria Cerulli, Kristijan H Kahler, et al.
The Primary Care Companion for CNS Disorders
|
March 8, 2013
Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder
Haijun Tian, Safiya Abouzaid, Susan Gabriel, et al.
Pharmacoepidemiology and Drug Safety
|
March 4, 2006
Methods for evaluation of medication adherence and persistence using automated databases
Susan E Andrade, Kristijan H Kahler, Feride Frech, et al.
Alzheimer Disease and Associated Disorders
|
August 16, 2012
Patient adherence to transdermal rivastigmine after switching from oral donepezil: a retrospective claims database study
Haijun Tian, Safiya Abouzaid, Wei Chen, et al.
Journal of the American Academy of Dermatology
|
January 11, 2003
Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis
Margaret C Reilly, Philip T Lavin, Kristijan H Kahler, et al.
Bone
|
August 21, 2007
Consequences of poor compliance with bisphosphonates
Becky A Briesacher, Susan E Andrade, Robert A Yood, et al.
Pharmacoepidemiology and Drug Safety
|
March 6, 2003
Safety and patient tolerance of standard and slow-release formulations of NSAIDs
Michael Langman, Sheldon X Kong, Qiaoyi Zhang, et al.
Page
of 5